Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
07 January 2026
General Assembly, General meetings

EGM January 2026 – Shares and voting rights statement Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Rapport AK réservée aux salariés Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Notice and Convening Brochure Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Proxy voting form Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Preliminary Notice of the General Meeting Open in new window

07 January 2026
General Assembly, General meetings

EGM January 2026 – Global delegation report Open in new window

29 December 2025
Financial statements and reports, Regulated information

ANNEX IX DECEMBER 2025 Open in new window

10 November 2025
Regulated information

ANNEX IX NOVEMBER 2025 Open in new window

15 October 2025
Investor newsletter

INVESTOR NEWSLETTER – OCTOBER 2025 (ENGLISH) Open in new window

06 October 2025
Investor newsletter

INVESTOR NEWSLETTER – OCTOBER 2025 (FRENCH) Open in new window

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 25
  • View next 9 articles
© 2026 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page